Ascendis Pharma A (ASND) Return on Invested Capital [ROIC] (2022 - 2026)
Ascendis Pharma A (ASND) recorded Return on Invested Capital [ROIC] of 0.00% in the quarter ended Jun 30, 2026, up 31.92 percentage points from -31.92% a year earlier and up 0.44 percentage points from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Return on Invested Capital [ROIC] (2022 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Ascendis Pharma A reported Return on Invested Capital [ROIC] of -12.74%, up 24.05 percentage points from the prior year.
- Annual Return on Invested Capital [ROIC] has a three-year change of +52.12 percentage points (years ended Dec 2022 to Dec 2025).
- Across earlier years, Return on Invested Capital [ROIC] came in at -36.79% in the year ended Dec 31, 2024 (+34.29 pp), -71.09% in the year ended Dec 31, 2023 (-6.23 pp) and -64.86% in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Return on Invested Capital [ROIC] in data going back to the quarter ended Mar 31, 2022.
- On a year-over-year basis, Return on Invested Capital [ROIC] has increased for ten consecutive quarters, with an average year-over-year change of +35.15 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Invested Capital [ROIC] in the last five years was a gain of 61.01 percentage points in the quarter ended Sep 30, 2024, against a drop of 55.63 percentage points in the quarter ended Sep 30, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -0.44% (quarter ended Mar 31, 2026), -13.35% (quarter ended Dec 31, 2025) and -16.58% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 0.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | -0.44% |
| Dec 31, 2025 | -13.35% |
| Sep 30, 2025 | -16.58% |
| Jun 30, 2025 | -31.92% |
| Mar 31, 2025 | -40.37% |
| Dec 31, 2024 | -32.88% |
| Sep 30, 2024 | -47.04% |
| Jun 30, 2024 | -63.56% |
| Mar 31, 2024 | -58.08% |
| Dec 31, 2023 | -81.84% |
| Sep 30, 2023 | -108.06% |
| Jun 30, 2023 | -93.28% |
| Mar 31, 2023 | -87.98% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | -52.42% |
| Jun 30, 2022 | -43.81% |
| Mar 31, 2022 | -44.04% |
API Access
Ascendis Pharma A Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();